In light of all these issues, this study aimed to assess the natural antibody response specific to the full-length S protein, its functional domains RBD (protein), and RBM (peptide) using plasma collected from COVID-19-positive patients and pre-COVID-19 participants from a malaria-endemic region. Here, PROS1 is linked to COVID-19.